
#https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335344/
#The NFÎºB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor positive breast cancers

#Suppl. Table 2 --> NIHMS1582585-supplement-4.xlsx
